City
Epaper

CDRI develops Omicron testing kit

By IANS | Updated: January 24, 2022 15:26 IST

Lucknow, Jan 24 The CSIR-Central Drug Research Institute (CDRI) has developed an indigenous RT-PCR diagnostic kit, called 'Om', ...

Open in App

Lucknow, Jan 24 The CSIR-Central Drug Research Institute (CDRI) has developed an indigenous RT-PCR diagnostic kit, called 'Om', for testing the new Omicron variant of Covid-19.

It is the first kit made by any government institution, and the third to be made indigenously, for specific testing of Omicron.

At present, two more such kits developed by private players are available in the market.

'Om' is likely to be launched in the second week of February, after it receives a nod from the Indian Council of Medical Research (ICMR).

A team of three scientists, led by senior principal scientist Atul Goel and four research scholars, have made the kit within two months.

The kit will cost around Rs 150 and give the test result in around two hours.

'Om' has been tested and validated by the head, microbiology department, Prof Amita Jain of the King George's Medical University.

Senior principal scientist, Atul Goel, said: "The biggest benefit of the kit would be that the patient will be aware if he or she is infected with Omicron or Delta. If one is infected by Omicron, he or she will not panic as this variant is milder than Delta."

He added that as Covid continues to mutate, diagnosis and treatment of different variants becomes difficult. Omicron, though milder in symptoms, is a super-spreader. It can be controlled if identified timely with the use of this kit.

Principal scientist, Niti Kumar, said: "Om will help in quick and cost-effective detection of Omicron as compared to genome sequencing."

He added: "This technology can be aligned for detection of other emerging variants of Covid and other respiratory infections."

CDRI director, Prof Tapas Kundu, said: "Our scientists have successfully developed INDICoV-Om for specific detection of Omicron. Ours is one of the few specific kits across the world for Omicron detection. Most of the kits do not confirm Omicron, therefore, this kit will be of great help."

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Csir-central drug research instituteIndian Council Of Medical ResearchAtul goelNiti kumar
Open in App

Related Stories

HealthICMR Issues Guidelines on Safe Tea Consumption Amid Cancer Concerns

NationalUnion Health Ministry Reviews Heatwave Preparedness and Fire Safety in Healthcare Facilities Nationwide

HealthICMR Issues New Dietary Guidelines for Tea and Coffee Consumption

BusinessGoel Ganga Group: Shaping Cities and Creating Exceptional Living Experiences

NationalPM to launch Sickle Cell Disease elimination campaign in MP today

Health Realted Stories

HealthCentre extends financial aid to indigenous indoor air purification solution

HealthChildhood exposure to bacterial toxin can trigger Colorectal cancer among the young: Study

HealthIndia achieves breakthrough in gene therapy for haemophilia: Minister

LifestyleWalking Tips for Summer: Know the Best time to Walk to Avoid Heatstroke

HealthCentre launches campaign to achieve 100 pc Measles-Rubella immunisation coverage